ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



First remarkable findings in comparison of patients in Siirt / Turkey in novel coronavirus (Covid-19) pandemic

Naci Omer Alayunt, Osman Ozudogru, Emrah Yerlikaya.



Abstract
Download PDF Post

In December 2019, a novel coronavirus (Covid-19) associated with human to human transmission and severe human infection has been recently reported from the city of Wuhan in China Hubei Province. The first Covid-19 in Turkey comparative findings of their patients can help spread the infection, early diagnosis, treatment and control. This study in Turkey Siirt State Hospital in Covid-19 diagnosed patients and 12 healthy normal consists of 12 patients. Data from electronic medical records were taken retrospectively and patient and control group data were compared statistically. Statistically decreased lymphocyte (1.23 ± 0.66), WBC (5.00 ± 1.50), neutrophil (3.32 ± 1.77), platelets (175.08 ± 44.18) in Covid-19 patients compared to the control group and increased D-Dimer (595.08 ± 185.87), ferritin (236.31 ± 50.36), CRP (12.43 ± 4.31), lactate (1.37 ± 0.39), CK (189.50 ± 63.66) levels, other clinical findings and CT images were found to be compatible with Covid-19. This study is the first comparative study on pandemic Covid-19 in Siirt/Turkey. These prognostic parameters are important for a specific clinical diagnosis, which may contribute to reflect the evolution of CT findings and the severe course of the disease and the worst clinical picture.

Key words: Computed tomography, Coronavirus, Covid-19, laboratory tests, pandemic







Bibliomed Article Statistics

26
27
33
25
34
15
27
24
23
33
47
17
R
E
A
D
S

16

13

10

13

17

15

12

11

9

17

19

7
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.